| P50 | author | Marilyn Huestis | Q60467738 |
| P2093 | author name string | Ariane Wohlfarth | |
| | Kayla N Ellefsen | |
| | Madeleine J Swortwood | |
| | Xingxing Diao | |
| | Marta Concheiro | |
| P2860 | cites work | Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV). | Q36548946 |
| | Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. | Q36590426 |
| | Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products | Q36610017 |
| | Suspected impaired driving case involving α-pyrrolidinovalerophenone, methylone and ethylone | Q38248827 |
| | Seizures associated with synthetic cathinone exposures in the pediatric population | Q40207751 |
| | Three fatal intoxications due to methylone | Q40286882 |
| | New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron | Q42707453 |
| | New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland | Q42743410 |
| | Mephedrone (4-methylmethcathinone)-related deaths | Q42744621 |
| | The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland | Q42946688 |
| | Acute methylone intoxication in an accidental drowning--a case report | Q43595279 |
| | Sudden cardiac death associated with methylone use. | Q44011078 |
| | Establishment of drug codes for 26 substances. Final rule | Q46271509 |
| | Analysis of 4-MEC in biological and non-biological material--three case reports | Q50056262 |
| | Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine fr | Q56689548 |
| | In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry | Q61037219 |
| | The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans | Q73197234 |
| | An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion | Q80859486 |
| | Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine | Q87518537 |
| | Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order | Q95563786 |
| | Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity | Q24631444 |
| | Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry | Q28212734 |
| | 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online | Q28250709 |
| | Pharmacological characterization of designer cathinones in vitro | Q28273207 |
| | Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry | Q28277604 |
| | Mephedrone: use, subjective effects and health risks. | Q30402845 |
| | Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry | Q31057190 |
| | Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin | Q34111094 |
| | Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV). | Q34122902 |
| | Drugs for youth via Internet and the example of mephedrone | Q34156700 |
| | The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). | Q34200334 |
| | Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States | Q34206558 |
| | Identification of cytochrome P450 enzymes involved in the metabolism of 4'-methoxy-alpha-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes | Q34269371 |
| | Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification | Q34270487 |
| | In vitro metabolism studies on mephedrone and analysis of forensic cases | Q34273882 |
| | Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results | Q34325173 |
| | Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA | Q34464722 |
| | Two Fatal Intoxications with the New Designer Drug Methedrone (4-Methoxymethcathinone) | Q34625141 |
| | New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques | Q34951585 |
| P921 | main subject | in silico | Q192572 |
| | metabolite identification | Q116678277 |
| P304 | page(s) | 61-75 | |
| P577 | publication date | 2015-08-05 | |
| P1433 | published in | Forensic Toxicology | Q15724497 |
| P1476 | title | 4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry | |
| P478 | volume | 34 | |